Haw ParHAWPF 95 ROA % is 5.61% as of Dec. 2025, which is 7% above its 10-year median of 5.26. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Haw Par ranks better than 68.49% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Haw Par's annualizedNet Income for the quarter that ended in Dec. 2025 was $188.0 Mil.
Haw Par's average Total Assets over the quarter that ended in Dec. 2025 was $3,351.9 Mil. Therefore, Haw Par's annualized ROA % for the quarter that ended in Dec. 2025 was 5.61%.
The historical rank and industry rank for Haw Par's ROA % or its related term are showing as below:
HAWPF'
s ROA % Range Over the Past 10 Years
Min: 3.53 Med: 5.26 Max: 6.17
Current: 6.17
During the past 13 years, Haw Par's highest ROA % was 6.17%. The lowest was 3.53%. And the median was 5.26%.
HAWPF's ROA % is ranked better than 68.49% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 2.685
vs HAWPF: 6.17
Haw Par (OTCPK:HAWPF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Haw Par ROA % Related Terms
Haw Par ROA % Historical Data
* Premium members only.
The historical data trend for Haw Par's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's ROA % distribution charts can be found below:
* The bar in red indicates where Haw Par's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Haw Par (HAWPF) has a ROA % of 5.61% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Haw Par and its competitors. This is near median its historical median of 5.26. Over the past decade, Haw Par's ROA % has ranged from 3.53 to 6.17. According to the industry distribution chart, Haw Par ranks #317 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 31.5%.
Is Haw Par's ROA % too high?
Haw Par's current ROA % of 5.61% is near median its 10-year median of 5.26. Over the past 10 years, this metric has ranged from a low of 3.53 to a high of 6.17. The Drug Manufacturers industry median ROA % is 2.69. Haw Par's value of 5.61% is 108.9% above this industry median. Based on the distribution chart, Haw Par ranks #317 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's ROA % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #317 out of 1006 companies for ROA %. This puts Haw Par in the upper half of its industry. The industry median ROA % is 2.69. Haw Par's value of 5.61% is 108.9% above this benchmark. Historically, Haw Par's own ROA % has ranged from 3.53 to 6.17 over the past decade. While the company's 10-year median is 5.26 vs. the industry median of 2.69, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.69, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current ROA % of 5.61% is 108.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current ROA % is 5.61%, which is near median its own 10-year median of 5.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current ROA % of 5.61%. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current ROA % is 5.61%, which is near median its 10-year median of 5.26 and 108.9% above the Drug Manufacturers industry median of 2.69. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Haw Par (HAWPF), the current ROA % is 5.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.
Key valuation signals for HAWPF:
ROA %: 5.61% (near median its 10-year median of 5.26)
GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
Industry Position: 108.9% above the Drug Manufacturers median (#317 of 1006)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score
Get the complete analysis for HAWPF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
